Your results have been filtered for all content relevant to "gold" within all Money Map Press subscriptions

Many investors are struggling to describe Monday's trading, and with good reason - the opening 1,000+ point drop was the single worst day opening in recorded stock market history on twice the monthly average volume. The selloff wiped $490 billion from emerging market equities alone, and some $5 trillion has been wiped out worldwide in the last few days according to Bloomberg.

 
Your current subscriptions do not allow access to this search result.
Learn More

It's been a little while since we checked in on one of my favorite big pharma companies, Abbott Laboratories (NYSE:ABT). So far the company has returned 31.23% versus the S&P 500, which has produced only 12.64% over the same time frame.

I'm happy with that - and I trust you are, too - considering how much runway there still is ahead.

Net income's up 68.6% year over year to $784 million. That's great and speaks to the consistent, savvy marketing and global branding that attracted us in the first place.

 
Your current subscriptions do not allow access to this search result.
Learn More

Today, I'm going to share with you an exciting new report that could deliver impressive profits in the next few months. As I write this, the entire country is undergoing a massive shift toward game-changing "Gold Chip" technology, and I'm going to show you how we plan to profit from it.

But first, I want to talk about Neurocrine Biosciences Inc. (NasdaqGS:NBIX).

Last week, NBIX traded above our outstanding profit target of $46.56 as recommended in Alert #134 on August 11, 2015, deliver 400% gains.

And the best part - NIBX just keeps climbing - it closed Monday's session up 415.15%.

Congratulations for everyone following along! If you participated in the NBIX trade, go please send me an email here. I'd love to hear about your success.

 
Your current subscriptions do not allow access to this search result.
Learn More

The market stopped us out of Envestnet Inc. (NYSE: ENV), our play on softbot technology for the financial services industry, after the company announced a bold new merger.

Envestnet announced yesterday that it is buying Yodlee Inc., (Nasdaq: YDLE), a provider of personal finance apps to 11 of the country's top 20 banks, for about $590 million.

Yodlee is a high-profile company right now. Just last week, it was featured in the Wall Street Journal highlighting its side business of selling "alternative data" to investment and research firms regarding bank-customer transactions.

 
Your current subscriptions do not allow access to this search result.
Learn More

All three major indices plunged more than 1% on Tuesday after the People's Bank of China (PBOC) decided to slash the value of the Chinese currency, the yuan, by 2%. Yesterday was the largest one-day fall for the currency against the dollar since 1994.

The decision will likely boost China's export levels and offer a jumpstart to its economy, which has seen its growth remain cool from double-digits just five years ago. The move also offered another boost to the U.S. dollar, sending oil priced down to six-month lows.

For nearly a decade, the nation has allowed its currency to appreciate; however, this decision is stirring the ire of economists and politicians in Washington, who argue that the nation's central bank is offering an unfair advantage to its companies. Former non-executive chairman of Morgan Stanley Asia, Stephen Roach, said yesterday that this could be the beginning of "a new and increasingly destabilizing skirmish in the ever-widening global currency war." Investors can expect New York Federal Reserve President William Dudley to discuss the topic this morning during a speech.

 
Your current subscriptions do not allow access to this search result.
Learn More

Last February, I recommended Chinese retail and Internet titan, Alibaba Group Holding Ltd. (NYSE:BABA) as the best play on the emerging integrated online/offline globally integrated retailing model I see ahead. It's big, a cash cow, and in a league of its own.

The stock is down 7.39% since then, but I'm not worried one bit, especially when it comes to headlines like those it made Monday.

In case you missed the story, Alibaba is spending $4.6 billion on a 19.99% stake in Suning Commerce in a deal that is CEO Jack Ma's biggest yet.

 
Your current subscriptions do not allow access to this search result.
Learn More

When I recommended Raytheon Co. (NYSE:RTN) back in July 2011, it was an unpopular choice because of sequestration concerns and weak market conditions making headlines at the time.

Yet, it's returned 165.67% since then versus the S&P 500, which has chalked up 59.05% over the same time frame.

Now the company is gathering strength for another move higher. What's more, Raytheon is still a great buy:

 
Your current subscriptions do not allow access to this search result.
Learn More